This page is a census, not a review. On 2026-09-16 we opened every GLP-1-named patch or patch-adjacent product URL we could identify and recorded what came back: the final URL after redirects, the HTTP status, the product title, the declared ingredients, the price and the disclaimer. Nothing here is graded. The reason is set out in the case against the category: no product in this category has been tested in a human trial, so there is no outcome to rank them by, and a table of invented scores would be worth less than a table of what they say about themselves.
What the census found was not the list we expected to write.
The category is renaming itself, and the timestamps prove it
| Brand and URL requested | What came back on 2026-09-16 |
|---|---|
patchaid.com /products/glp-1-support-patch-pack |
Redirect → /products/premium-metabolic-support-patch-pack, titled "Premium Metabolic Support Patch Pack". "GLP-1" appears 4 times in the page source. |
kindpatches.com /products/glp-1-patches |
Redirect → /products/berberine-patches, titled "Berberine Patches (GLP-1 Friendly)". "GLP-1" appears 51 times in the page source. |
kindpatches.com /pages/glplp-usv2 |
404 Not Found |
humnutrition.com /product/glp-1-detox-bundle |
404 Not Found |
activepatches.com /products/glp-1-patch |
404 Not Found |
thepatchremedy.com /products/natural-metabolise-patch |
404 Not Found |
sensolin.com /products/glp-1-natural-weight-loss |
Resolves to a parked page offering the domain for sale |
triquetrahealth.com /products/glp-activate |
Live — but an oral capsule, not a patch |
| glp1patches.org | Resolves; no page title in the source |
Two live patch products out of nine URLs, and both of them renamed.
The contrast between the two renames is the most interesting number in the census. PatchAid appears to have actually retreated from the term: four mentions left on a page that used to be named for it. Kind Patches changed the product's name and kept the term fifty-one times on the same page, including in the title itself as "(GLP-1 Friendly)".
That second pattern is not our characterisation. It is the allegation in a lawsuit.
The court filing that describes the rename
On 2025-10-31, a complaint captioned Alaimo v. Kind Patches Limited, docket 25-cv-6092, was filed against the company. Its core allegation is that Kind Patches "falsely markets its GLP-1 patches as able to deliver effects comparable to those conferred by name-brand GLP-1 prescription medications such as Ozempic and Wegovy."
On the renaming specifically, the filing states that the company "has pivoted to calling its GLP-1 patches 'Berberine Patches' to ostensibly mitigate allegations of false advertising," and contends that despite the change, "the marketing language around them is identical, and influencers and social media ads continue to describe them as a legitimate GLP-1 agonist."
These are allegations in a civil complaint. They have not been proved, the company is entitled to defend them, and nothing here should be read as a finding that any of them is true. What we can verify independently is narrow and factual: on 2026-09-16, ten and a half months after the filing, the renamed page still carried the phrase GLP-1 fifty-one times.
What is actually on the panels
Neither live product claims to contain a GLP-1 drug, and both carry the statutory disclaimer. These are the sellers' own declared ingredients, read on 2026-09-16.
PatchAid — Premium Metabolic Support Patch Pack, $99.95 for a 30-day supply
The pack contains five different patches. The one carrying the weight-related claims is the Slim Trim patch:
| Ingredient | Declared amount |
|---|---|
| Berberine | 400 mg |
| Green tea | 400 mg |
| Cha de bugre | 400 mg |
| Turmeric | 400 mg |
| Lotus leaf extract | 200 mg |
| Saffron extract | 80 mg |
| Fucoxanthin | 80 mg |
| Chromium picolinate | 200 mcg |
The claims attached to the individual patches are hedged throughout — "may support fat metabolism and energy levels", "may promote normal hunger and support normal metabolism", "may support hydration balance and steady energy during fasting windows". The page carries the disclaimer verbatim: "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
Kind Patches — Berberine Patches (GLP-1 Friendly), listed between $12.75 and $15.00
| Component | Declared amount |
|---|---|
| Blend of berberine extract, pomegranate extract and cinnamon extract | 13.25 mg combined |
| Vitamin B complex (B1, B2, B3, B6, B9, B12) | 8.25 mg combined |
| L-glutamine | 3.5 mg |
| Chromium | 35 mcg |
Triquetra Health — GLP-Activate, an oral capsule and not a patch. Berberine HCl (40:1), green tea extract (50% EGCG), organic Ceylon cinnamon, aloe vera (200:1), Curcumin C3 Complex (95% curcuminoids), taurine, AXIVITE phenylcapsaicin, boron glycinate. The company's own copy states that the product "does not contain synthetic GLP-1 and is not a substitute for GLP-1 agonist drugs." Included here only because it appears in searches for patch brands; because it is swallowed, it does not raise the statutory problem described below.
Two numbers to hold the panels against
The amounts above are declared per patch. Two published figures give them a scale.
The berberine dose that has been tested is 1,000 mg a day, taken orally. A double-blind randomised trial of 337 people published in JAMA Network Open in January 2026 gave exactly that for six months and found no difference from placebo in visceral fat or liver fat. The largest amount declared on any patch here is 400 mg — and it is on an adhesive rather than swallowed. We set out that trial in full on GLP-1 supplements. The probiotic products sold beside the patches are set against their own claim text on the GLP-1 boosters page.
Nothing on these panels has been shown to cross skin. A ClinicalTrials.gov search on 2026-09-16 returned zero studies for "transdermal berberine". The chemistry argument, including why molecules of this kind are the wrong shape for the route, is on the patch category page.
The part of the census that is not about any brand
The only peer-reviewed survey of this category is White, Tai and Nuzi in Annals of Pharmacotherapy, August 2026 (60(8):813-816). It counted 24 transdermal patch dietary-supplement products and one gel, averaging seven ingredients each, with berberine the most frequently listed — which matches what we found brand by brand.
Its central argument is statutory and applies to every product in the table above that is worn rather than swallowed. The Dietary Supplement Health and Education Act defines a dietary supplement as a product intended for ingestion. On the authors' reading, a supplement delivered through the skin therefore is not one, and the whole category is unlawfully marketed regardless of what is in it.
The survey also reports that no product posted a certificate of analysis, and that many lacked the FDA disclaimer altogether. That absence is why this page reproduces ingredient panels as claims. Nobody outside these companies has published a verification that the contents match the label.
How to re-run this census
Everything above is a snapshot with a date on it, and the whole point of a census is that somebody else can repeat it. Request each URL in the first table, follow redirects, and record the final URL, the status code and the page title. Count occurrences of the string "GLP-1" in the source. The lawsuit is searchable by its caption and docket number. The survey is searchable by DOI, 10.1177/10600280251407145.
Prices move, pages change and products are discontinued — four of these URLs already 404 and one brand's domain is for sale. If you are reading this long after September 2026, treat the table as a record of that date rather than as a description of the market now.
For the questions underneath this one, the category page asks whether GLP-1 patches work at all, the oral half of the same market is GLP-1 supplements, and the physiology that all of it is named after is on natural GLP-1.